Zyrtec-D 12 Hour 5 mg/120 mg Extended Release Tablets (Pfizer, USA)
Sponsors
Sandoz
Conditions
Allergies
Phase 1
To Demonstrate the Relative Bioavailability of Cetirizine Hydrochloride/Pseudoephedrine Hydrochloride 5 mg/120 mg Extended Release (ER) Tablets Under Fasting Conditions
CompletedNCT00881127
Start: 2005-07-31End: 2005-07-31Updated: 2017-03-28
To Demonstrate the Relative Bioavailability of Cetirizine Hydrochloride/Pseudoephedrine Hydrochloride 5 mg/120 mg Extended Release (ER) Tablets Under Fed Conditions
CompletedNCT00881634
Start: 2005-06-30End: 2005-07-31Updated: 2017-03-28